Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope

Despite recent advances in therapeutic options, hepatitis C virus (HCV) remains a severe global disease burden, and a vaccine can substantially reduce its incidence. Due to its extremely high sequence variability, HCV can readily escape the immune response; thus, an effective vaccine must target con...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Virol
Autori principali: Pierce, Brian G., Boucher, Elisabeth N., Piepenbrink, Kurt H., Ejemel, Monir, Rapp, Chelsea A., Thomas, William D., Sundberg, Eric J., Weng, Zhiping, Wang, Yang
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2017
Soggetti:
Vaccines and Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5625506/
https://ncbi.nlm.nih.gov/pubmed/28794021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01032-17
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi